000074954 001__ 74954
000074954 005__ 20200117221609.0
000074954 0247_ $$2doi$$a10.1038/s41598-018-29985-4
000074954 0248_ $$2sideral$$a107667
000074954 037__ $$aART-2018-107667
000074954 041__ $$aeng
000074954 100__ $$aGarcía-Esquinas, E.
000074954 245__ $$aModerate alcohol drinking is not associated with risk of depression in older adults
000074954 260__ $$c2018
000074954 5060_ $$aAccess copy available to the general public$$fUnrestricted
000074954 5203_ $$aThe scarce research on the effects of moderate alcohol consumption on mental health among older adults suggests a protective effect against depression. We prospectively examined the association between patterns of moderate alcohol consumption, depression and psychological distress, using information from 5, 299 community-dwelling older adults from the ELSA and Seniors-ENRICA cohorts. A Mediterranean drinking pattern (MDP) was defined as moderate alcohol intake (<40 g/day for men; <24 g/day for women) with a preference for wine and drinking only with meals. Depression was ascertained with the 10-item Geriatric Depression Scale (GDS-10), a self-report of clinically-diagnosed depression, or being on anti-depressant medication (Seniors-ENRICA); and with the 8-item Center for Epidemiologic Studies Depression Scale (CES-D) (ELSA). Psychological distress was assessed with the General Health Questionnaire-12 (GHQ-12). Compared to never drinkers, moderate drinkers showed comparable scores on the ENRICA-GDS-10 (PRR (95%CI): 1.03 (0.84–1.26)), the ENRICA-GHQ-12 (0.88 (0.73–1.06)), the ELSA-CES-D (0.92 (0.79–1.06)) and the ELSA-GHQ-12 (0.75 (0.55–1.01). The MDP was not associated with the GDS-10 or GHQ-12 scores, or with clinically-diagnosed depression; however drinkers with a preference for wine showed an increased number of psychological distress symptoms (1.31 (1.03–1.66)). In conclusion, we found no consistent protective association between moderate alcohol consumption and depression in older adults.
000074954 536__ $$9info:eu-repo/grantAgreement/ES/MSCBS/Plan Nacional sobre Drogas 02-2014$$9info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI16-00609$$9info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI12-1166$$9This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No H2020 635316-ATHLOS$$9info:eu-repo/grantAgreement/EC/H2020/635316/EU/Ageing Trajectories of Health: Longitudinal Opportunities and Synergies/ATHLOS$$9info:eu-repo/grantAgreement/EC/FP7/305483/EU/Utility of omic-based biomarkers in characterizing older individuals at risk for frailty, its progression to disability and general consequences to health and well-being - The FRAILOMIC Initiative/FRAILOMIC
000074954 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000074954 590__ $$a4.011$$b2018
000074954 591__ $$aMULTIDISCIPLINARY SCIENCES$$b14 / 69 = 0.203$$c2018$$dQ1$$eT1
000074954 592__ $$a1.414$$b2018
000074954 593__ $$aMultidisciplinary$$c2018$$dQ1
000074954 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000074954 700__ $$aOrtolá, R.
000074954 700__ $$aGalán, I.
000074954 700__ $$aSoler-Vila, H.
000074954 700__ $$0(orcid)0000-0003-3963-0846$$aLaclaustra, M.
000074954 700__ $$aRodríguez-Artalejo, F.
000074954 773__ $$g8, 1 (2018), 11512 [10 pp]$$pSci. rep.$$tSCIENTIFIC REPORTS$$x2045-2322
000074954 8564_ $$s990449$$uhttps://zaguan.unizar.es/record/74954/files/texto_completo.pdf$$yVersión publicada
000074954 8564_ $$s114306$$uhttps://zaguan.unizar.es/record/74954/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000074954 909CO $$ooai:zaguan.unizar.es:74954$$particulos$$pdriver
000074954 951__ $$a2020-01-17-21:48:01
000074954 980__ $$aARTICLE